S&P 500 index data: S&P 500 Copyright ©
|Cynosure Receives Expanded FDA Clearance to Market PicoSure® for Treatment of Wrinkles|
|Cynosure To Host Third-Quarter 2014 Financial Results Conference Call On October 28|
|Cynosure Reports Record Third-Quarter Revenue of $71.5 Million, Up 18% Year-Over-Year|
|Cynosure Signs Exclusive Agreement to Market MonaLisa Touch™ in North America for Gynecology Indications|
|Cynosure Discusses Favorable Clinical Data from Trial of MonaLisa Touch™ Laser Treatment|
Click above to view more mutual fund data and stats for cyno - Cynosure Inc Class A.